Ani Pharmaceuticals (ANIP) Debt Ratio (2010 - 2026)

Ani Pharmaceuticals has disclosed Debt Ratio across 17 years of filings, most recently posting 0.2 for Q2 2026.

• In Q2 2026, Debt Ratio fell 13.89% year-over-year to 0.2; the TTM figure through Jun 2026 stood at 0.2 (down 13.89% YoY), while the FY2025 annual figure was 0.21, down 13.39% from the prior year.
• Debt Ratio came in at 0.2 for Q2 2026 at Ani Pharmaceuticals, down from 0.21 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.4 in Q1 2023 to a low of 0.2 in Q2 2026.
• Average Debt Ratio over 5 years is 0.3, with a median of 0.31 recorded in 2024.
• Year-over-year, Debt Ratio grew 4.48% in 2023 and slipped 28.39% in 2024.
• Over 5 years, Debt Ratio stood at 0.38 in 2022, then slipped by 12.86% to 0.33 in 2023, then fell by 24.56% to 0.25 in 2024, then decreased by 13.39% to 0.21 in 2025, then declined by 5.97% to 0.2 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.2 in Q2 2026, 0.21 in Q1 2026, and 0.21 in Q4 2025.